Drug intelligence / Profile preview

Human natural killer cell preparation (Shanghai Life Science & Technology)

Development stage
Preclinical
Lead developer
Shanghai Life Science & Technology
Modality
CAR-NK Cells → Other Engineered Cells → Adoptive Cell Transfer → Cell Therapies, Lymphokine-Activated Killer Cells → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies
Administration
Intravenous
01

Overview

Human natural killer cell preparation is an adoptive cell therapy being developed by Shanghai Life Science & Technology (莱馥生命科技) for the treatment of solid tumors. As part of the company's 'Universal Somatic Cell Drug' category, this therapy utilizes natural killer (NK) cells, which are innate immune effector cells capable of identifying and lysing malignant cells without prior sensitization. NK cells exert their anti-tumor effects through the release of cytotoxic granules containing perforin and granzymes, as well as through the expression of death ligands like TRAIL and FasL. The preparation is designed to bolster the patient's innate immune response to overcome the immunosuppressive microenvironment typically found in solid malignancies.

Other names
人自然杀伤细胞制剂NK Cell PreparationNK Cell

Beyond the preview

Go deeper on Human natural killer cell preparation (Shanghai Life Science & Technology).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human natural killer cell preparation (Shanghai Life Science & Technology).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call